Announcements

The latest Impact Factors have been released and are updated in our site!

Not a Current Subscriber?

Subscribe Now

5921 Journals

5002 Congresses

10900+ Unique Records

Immuno-Oncology Technology

Title Abbreviation

IOTECH

Electronic ISSN

2590-0188

Therapeutic Area

Biotechnology, Cytology/Cell Biology, Hematology, Immunology, Molecular Medicine, Oncology, Vaccines/Vaccinology

Readership

Biomedical Engineers/Technologists, Biomedical Researchers, Cell Biologists, Clinicians, Cytologists/Cell Biologists, Hematologists, Immunologists, Molecular Biologists, Oncologists, Researchers

Scope

Immuno-Oncology Technology (IOTECH) is a new, peer-reviewed open access journal from ESMO publishing high quality original research articles, reviews and editorials focusing on novel immuno-oncology topics and developments, both clinically and preclinically. Led by an international team of expert Editors and Editorial Board members IOTECH will focus on: • Adoptive cell therapy, including tumor infiltrating lymphocytes and gene modified cells; • Cancer vaccine development, including neoantigen vaccines; • Intratumoral immunotherapy; • New macromolecules, such as bispecific or trispecific antibodies, nanobodies, designed ankyrin repeat proteins and immunocytokines; • Biomarker research aimed towards developing precision immunotherapy, including immuno-oncology diagnostics both in peripheral blood (ctDNA, chemokines profiles etc.) and in the tumor, including tumor mutational burden, single cell analysis (genomics, transcriptomics, proteomics), metabolomics, molecular imaging and microbiome; • First in human trials, phase I and newly designed phase II trials.

Sponsoring Association(s)

European Society for Medical Oncology (ESMO)

Publisher Name

Elsevier Inc - NY

To see more details about Immuno-Oncology Technology, Subscribe Now!

Electronic Circulation Acceptance to Online Publication Rejection Rate Frequency Author Submission Guidelines

Testimonials

"PubsHub [Journals & Congresses] is an indispensable tool when trying to find the perfect home for a manuscript. It is an unbeatable aid when it comes to wise and efficient journal selection."
	– Kait G Editorial-Project Editor
"It’s useful for establishing publication timelines, communicating them to management and setting expectations accordingly"
	– Michael K. Medical Communications Leader

Journals ● Congresses ● Associations

Privacy Policy ● Terms of Service ● Glossary ● Contact Us